Results Of Oxford COVID-19 Vaccine’s Human Trials Will Come Out By June

With every day passing and more vaccines being tested, we are one step closer to finding a cure for COVID-19.

A few weeks ago, a team under the guidance of vaccinologist Sarah Gilbert, a team of researchers at Oxford University has put its vaccine in human trials.

And last week, it was revealed that the monkeys injected with the test vaccine from the Oxford group haven’t contracted with SARS-CoV-2, the virus behind COVID-19, after 28 days.

In an interview with NBC News, Sir John Bell, Oxford University’s Regius Professor of Medicine, said that the results for the human trials of the vaccine could come out by June this year.

He stated that from phase two of the trials, by next month, the researchers would collect enough data to have a concrete basis for the vaccine’s efficacy.

And in his opinion, the vaccine could have a very high chance of success. In his interview, Bell also emphasized the differences between COVID-19 and normal flu.

He also revealed that the Oxford team is making sure that safety is the first priority when fast-tracking the vaccine.

According to Professor Sarah Gilbert, the “ChAdOx1” vaccine can potentially fight the SARS-CoV-2 virus. She had previously mentioned that she was 80% confident about the success of the vaccine.

Serum Institute of India will be in charge of manufacturing the Oxford vaccine based on Oxford University’s human trials. And from May onwards, Serum Institute will start their own trials.

>>> The Genius Woman Behind The COVID-19 Vaccine That Might Save Us All